Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
Did you mean: (antipsychotic)?
131,241 results
  • Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia. [Journal Article]
    J Clin Psychiatry 2019; 80(5)Kane JM, Correll CU
  • Acute and long-term objectives must be linked early in the treatment of schizophrenia. Maintenance therapy is pivotal in relapse prevention. Relapses are serious events that alter disease trajectory and are most often related to nonadherence. Patients with schizophrenia have a substantial risk of relapse, especially when they are nonadherent to antipsychotics. Because relapses are accompanied by …
  • Possible varenicline withdrawal-induced akathisia: A case report. [Case Reports]
    Ment Health Clin 2019; 9(5):322-325Smith TR, Dabaja MH, Farhat MJ
  • Akathisia is a relatively common adverse effect that may emerge during treatment with antipsychotics and other medication classes. We present a case of akathisia that may have been induced by the abrupt discontinuation of varenicline and review existing literature related to this phenomenon. A 46-year-old female with a past psychiatric history of bipolar disorder and borderline personality disord…
  • Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report. [Case Reports]
    Ment Health Clin 2019; 9(5):315-317Williams GD
  • Angioedema is characterized by marked swelling of the subcutaneous or submucosal tissue and may affect various parts of the body, including the face, mouth, and extremities. Angioedema has specifically been associated with the use of several antipsychotic agents, including clozapine, olanzapine, iloperidone, haloperidol, quetiapine, paliperidone, ziprasidone, risperidone, and chlorpromazine. A 67…
  • Long-Acting Injectable Versus Oral Antipsychotics for Restoration of Competency to Stand Trial. [Journal Article]
    J Am Acad Psychiatry Law 2019Ghossoub E, Minchin S, … Newman WJ
  • Treatment with antipsychotics is a mainstay of trial competency restoration, particularly given that most defendants deemed incompetent to stand trial have psychotic illnesses. We explored the association between competency restoration and antipsychotic type in a retrospective sample of defendants diagnosed with psychotic disorders and deemed incompetent to stand trial. Using regression models, w…
  • Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review. [Journal Article]
    J Psychopharmacol 2019; :269881119872194Taylor RW, Marwood L, … Cleare AJ
  • CONCLUSIONS: This review highlights the importance of early response as a predictor of pharmacological augmentation outcome, with implications for both the monitoring and treatment of resistant unipolar patients. Further replication is needed across specific interventions to fully assess the generalisability of this finding. However, the clear lack of consistent evidence for other predictive factors both within and across treatments, and the scarce examination of psychological augmentation, demonstrates the need for much more research of a high quality if response prediction is to improve outcomes for patients with treatment-resistant depression.
New Search Next